Literature DB >> 1401073

Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.

V Sarabia1, L Lam, E Burdett, L A Leiter, A Klip.   

Abstract

Primary human muscle cell cultures were established and the regulation of glucose transport was investigated. Primary cultures were allowed to proceed to the stage of myotubes through fusion of myoblasts or were used for clonal selection based on fusion potential. In clonally selected cultures, hexose (2-deoxy-glucose) uptake into myotubes was linear within the time of study and inhibitable by cytochalasin B (IC50 = 400 nM). Cytochalasin B photolabeled a protein(s) of 45,000-50,000 D in a D-glucose-protectable manner, suggesting identity with the glucose transporters. In the myotube stage, the cells expressed both the GLUT1 and GLUT4 glucose transporter protein isoforms at an average molar ratio of 7:1. Preincubation in media of increasing glucose concentrations (range 5-25 mM) progressively decreased the rate of 2-deoxyglucose uptake. Insulin elevated 2-deoxyglucose uptake in a dose-dependent manner, with half maximal stimulation achieved at 3.5 nM. Insulin also stimulated the transport of the nonmetabolizable hexose 3-O-methylglucose, as well as the activity of glycogen synthase, responsible for nonoxidative glucose metabolism. The oral antihyperglycemic drug metformin stimulated the cytochalasin B-sensitive component of both 2-deoxyglucose and 3-O-methylglucose uptake. Maximal stimulation was observed at 8 h of exposure to 50 microM metformin, and this effect was not prevented by incubation with the protein-synthesis inhibitor cycloheximide. The relative effect of metformin was higher in cells incubated in 25 mM glucose than in 5 mM glucose, consistent with its selective action in hyperglycemic conditions in vivo. Metformin (50 microM for 24 h) was more effective than insulin (1 microM for 1 h) in stimulating hexose uptake and the hormone was effective on top of the stimulation caused by the biguanide, suggesting independent mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401073      PMCID: PMC443184          DOI: 10.1172/JCI116005

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  The use of human skeletal muscle in vitro for biochemical and pharmacological studies of glucose uptake.

Authors:  K N Frayn; P I Adnitt; P Turner
Journal:  Clin Sci       Date:  1973-01       Impact factor: 6.124

2.  Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats.

Authors:  K N Frayn; P I Adnitt
Journal:  Biochem Pharmacol       Date:  1972-12-01       Impact factor: 5.858

3.  Labelling of the human erythrocyte glucose transporter with 3H-labelled cytochalasin B occurs via protein photoactivation.

Authors:  M Deziel; W Pegg; E Mack; A Rothstein; A Klip
Journal:  Biochim Biophys Acta       Date:  1984-05-30

4.  Role of glucose transport in the postreceptor defect of non-insulin-dependent diabetes mellitus.

Authors:  T P Ciaraldi; O G Kolterman; J A Scarlett; M Kao; J M Olefsky
Journal:  Diabetes       Date:  1982-11       Impact factor: 9.461

5.  Activation of glucose transport in diabetic muscle: responses to contraction and insulin.

Authors:  H Wallberg-Henriksson; J O Holloszy
Journal:  Am J Physiol       Date:  1985-09

6.  Induction of sugar uptake response to insulin by serum depletion in fusing L6 myoblasts.

Authors:  A Klip; G Li; W J Logan
Journal:  Am J Physiol       Date:  1984-09

7.  Mechanism of metformin action in non-insulin-dependent diabetes.

Authors:  R A Jackson; M I Hawa; J B Jaspan; B M Sim; L Disilvio; D Featherbe; A B Kurtz
Journal:  Diabetes       Date:  1987-05       Impact factor: 9.461

8.  Identification of the glucose transporter in rat skeletal muscle.

Authors:  A Klip; D Walker; K J Ransome; D W Schroer; G E Lienhard
Journal:  Arch Biochem Biophys       Date:  1983-10-01       Impact factor: 4.013

9.  Effect of metformin on glucose metabolism in mouse soleus muscle.

Authors:  C J Bailey; J A Puah
Journal:  Diabete Metab       Date:  1986-08

10.  An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects.

Authors:  G L Dohm; E B Tapscott; W J Pories; D J Dabbs; E G Flickinger; D Meelheim; T Fushiki; S M Atkinson; C W Elton; J F Caro
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

View more
  52 in total

1.  Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.

Authors:  V Luna; L Casauban; M P Sajan; J Gomez-Daspet; J L Powe; A Miura; J Rivas; M L Standaert; R V Farese
Journal:  Diabetologia       Date:  2006-01-05       Impact factor: 10.122

Review 2.  Insulin resistance and improvements in signal transduction.

Authors:  Nicolas Musi; Laurie J Goodyear
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  The AMPK β2 subunit is required for energy homeostasis during metabolic stress.

Authors:  Biplab Dasgupta; Jeong Sun Ju; Yo Sasaki; Xiaona Liu; Su-Ryun Jung; Kazuhiko Higashida; Diana Lindquist; Jeffrey Milbrandt
Journal:  Mol Cell Biol       Date:  2012-05-14       Impact factor: 4.272

4.  Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions.

Authors:  Guruprasad R Pattar; Lixuan Tackett; Ping Liu; Jeffrey S Elmendorf
Journal:  Mutat Res       Date:  2006-07-25       Impact factor: 2.433

Review 5.  The barrier within: endothelial transport of hormones.

Authors:  Cathryn M Kolka; Richard N Bergman
Journal:  Physiology (Bethesda)       Date:  2012-08

6.  Metformin activates AMP kinase through inhibition of AMP deaminase.

Authors:  Jiangyong Ouyang; Rahulkumar A Parakhia; Raymond S Ochs
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

7.  Metformin enhances insulin signalling in insulin-dependent and-independent pathways in insulin resistant muscle cells.

Authors:  Naresh Kumar; Chinmoy S Dey
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

Review 8.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

9.  Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice.

Authors:  M H Mooney; S Fogarty; C Stevenson; A M Gallagher; P Palit; S A Hawley; D G Hardie; G D Coxon; R D Waigh; R J Tate; A L Harvey; B L Furman
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

10.  Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance.

Authors:  Emily M Horvath; Lixuan Tackett; Alicia M McCarthy; Priya Raman; Joseph T Brozinick; Jeffrey S Elmendorf
Journal:  Mol Endocrinol       Date:  2007-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.